MedPath

Dexamethasone

dexamethasone 4mg

Approved
Approval ID

674fd223-fd39-e608-e053-2991aa0a9bdc

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 19, 2022

Manufacturers
FDA

RedPharm Drug

DUNS: 828374897

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Dexamethasone

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code67296-0326
Application NumberANDA084612
Product Classification
M
Marketing Category
C73584
G
Generic Name
Dexamethasone
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 19, 2022
FDA Product Classification

INGREDIENTS (8)

D&C YELLOW NO. 10Inactive
Code: 35SW5USQ3G
Classification: IACT
SUCROSEInactive
Code: C151H8M554
Classification: IACT
FD&C GREEN NO. 3Inactive
Code: 3P3ONR6O1S
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
FD&C YELLOW NO. 6Inactive
Code: H77VEI93A8
Classification: IACT
DEXAMETHASONEActive
Quantity: 4 mg in 1 1
Code: 7S5I7G3JQL
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Dexamethasone - FDA Drug Approval Details